lptG contributes to changes in membrane permeability and the emergence of multidrug hypersusceptibility in a cystic fibrosis isolate of Pseudomonas aeruginosa

Abstract Purpose In the lungs of cystic fibrosis patients, Pseudomonas aeruginosa is exposed to a myriad of antibiotics leading to alterations in antibiotic susceptibility. This study identifies mutations resulting in hypersusceptibility in isogenic mutants of a P. aeruginosa clinical isolate, PA34....

Full description

Bibliographic Details
Main Authors: Lucas B. Harrison, Randal C. Fowler, Baha Abdalhamid, Anna Selmecki, Nancy D. Hanson
Format: Article
Language:English
Published: Wiley 2019-11-01
Series:MicrobiologyOpen
Subjects:
Online Access:https://doi.org/10.1002/mbo3.844
_version_ 1819111417274433536
author Lucas B. Harrison
Randal C. Fowler
Baha Abdalhamid
Anna Selmecki
Nancy D. Hanson
author_facet Lucas B. Harrison
Randal C. Fowler
Baha Abdalhamid
Anna Selmecki
Nancy D. Hanson
author_sort Lucas B. Harrison
collection DOAJ
description Abstract Purpose In the lungs of cystic fibrosis patients, Pseudomonas aeruginosa is exposed to a myriad of antibiotics leading to alterations in antibiotic susceptibility. This study identifies mutations resulting in hypersusceptibility in isogenic mutants of a P. aeruginosa clinical isolate, PA34. Methods PA34 was exposed to subinhibitory concentrations of doripenem or meropenem during growth to mid‐log phase. Antibiotic susceptibility of surviving colonies was determined by agar dilution. Two carbapenem‐resistant colonies hypersusceptible to non‐carbapenem antibiotics were selected for further analysis. Antibiotic resistance gene expression was evaluated by RT‐rtPCR and OprD production by SDS‐PAGE. PA34 and isogenic mutants were evaluated with whole genome sequencing. Sequence variants were confirmed by Sanger sequencing, and cognate genes in eight carbapenem‐resistant clinical isolates hypersusceptible to non‐carbapenem antibiotics were sequenced. Lipopolysaccharide preparations of PA34 and hypersusceptible mutants were evaluated with ProQ‐Emerald stain. Results Isogenic mutants showed 4‐ to 8‐fold MIC increase for imipenem, meropenem, and doripenem. However, they were hypersusceptible (≥4‐fold MIC decrease) to aminoglycosides, fluoroquinolones, and non‐carbapenem β‐lactams. Expression of ampC or mex‐opr efflux pumps was unchanged, but OprD production was decreased. Mutations causing Q86H AlgU and G77C LptG amino acid substitutions and nonsense mutations within OprD were observed in both mutants. Lipopolysaccharide modifications were observed between isogenic mutants and PA34. Non‐synonymous mutations in LptF or LptG were observed in 6/8 hypersusceptible clinical isolates resistant to carbapenem antibiotics. Conclusion Evaluation of hypersusceptible mutants identified the association between lptG and a hypersusceptible phenotype. Modifications in lipopolysaccharide profiles suggests LptG modification interferes with lipopolysaccharide transport and contributes to hypersusceptibility.
first_indexed 2024-12-22T03:57:17Z
format Article
id doaj.art-1165e968cbc74244b6e154498d4ed19c
institution Directory Open Access Journal
issn 2045-8827
language English
last_indexed 2024-12-22T03:57:17Z
publishDate 2019-11-01
publisher Wiley
record_format Article
series MicrobiologyOpen
spelling doaj.art-1165e968cbc74244b6e154498d4ed19c2022-12-21T18:39:50ZengWileyMicrobiologyOpen2045-88272019-11-01811n/an/a10.1002/mbo3.844lptG contributes to changes in membrane permeability and the emergence of multidrug hypersusceptibility in a cystic fibrosis isolate of Pseudomonas aeruginosaLucas B. Harrison0Randal C. Fowler1Baha Abdalhamid2Anna Selmecki3Nancy D. Hanson4Department of Medical Microbiology and Immunology Creighton University Omaha NebraskaDepartment of Medical Microbiology and Immunology Creighton University Omaha NebraskaDepartment of Pathology and Microbiology University of Nebraska Medical Center OmahaDepartment of Medical Microbiology and Immunology Creighton University Omaha NebraskaDepartment of Medical Microbiology and Immunology Creighton University Omaha NebraskaAbstract Purpose In the lungs of cystic fibrosis patients, Pseudomonas aeruginosa is exposed to a myriad of antibiotics leading to alterations in antibiotic susceptibility. This study identifies mutations resulting in hypersusceptibility in isogenic mutants of a P. aeruginosa clinical isolate, PA34. Methods PA34 was exposed to subinhibitory concentrations of doripenem or meropenem during growth to mid‐log phase. Antibiotic susceptibility of surviving colonies was determined by agar dilution. Two carbapenem‐resistant colonies hypersusceptible to non‐carbapenem antibiotics were selected for further analysis. Antibiotic resistance gene expression was evaluated by RT‐rtPCR and OprD production by SDS‐PAGE. PA34 and isogenic mutants were evaluated with whole genome sequencing. Sequence variants were confirmed by Sanger sequencing, and cognate genes in eight carbapenem‐resistant clinical isolates hypersusceptible to non‐carbapenem antibiotics were sequenced. Lipopolysaccharide preparations of PA34 and hypersusceptible mutants were evaluated with ProQ‐Emerald stain. Results Isogenic mutants showed 4‐ to 8‐fold MIC increase for imipenem, meropenem, and doripenem. However, they were hypersusceptible (≥4‐fold MIC decrease) to aminoglycosides, fluoroquinolones, and non‐carbapenem β‐lactams. Expression of ampC or mex‐opr efflux pumps was unchanged, but OprD production was decreased. Mutations causing Q86H AlgU and G77C LptG amino acid substitutions and nonsense mutations within OprD were observed in both mutants. Lipopolysaccharide modifications were observed between isogenic mutants and PA34. Non‐synonymous mutations in LptF or LptG were observed in 6/8 hypersusceptible clinical isolates resistant to carbapenem antibiotics. Conclusion Evaluation of hypersusceptible mutants identified the association between lptG and a hypersusceptible phenotype. Modifications in lipopolysaccharide profiles suggests LptG modification interferes with lipopolysaccharide transport and contributes to hypersusceptibility.https://doi.org/10.1002/mbo3.844carbapenem resistancecystic fibrosishypersusceptibilitylipopolysaccharideslptGsubinhibitory
spellingShingle Lucas B. Harrison
Randal C. Fowler
Baha Abdalhamid
Anna Selmecki
Nancy D. Hanson
lptG contributes to changes in membrane permeability and the emergence of multidrug hypersusceptibility in a cystic fibrosis isolate of Pseudomonas aeruginosa
MicrobiologyOpen
carbapenem resistance
cystic fibrosis
hypersusceptibility
lipopolysaccharides
lptG
subinhibitory
title lptG contributes to changes in membrane permeability and the emergence of multidrug hypersusceptibility in a cystic fibrosis isolate of Pseudomonas aeruginosa
title_full lptG contributes to changes in membrane permeability and the emergence of multidrug hypersusceptibility in a cystic fibrosis isolate of Pseudomonas aeruginosa
title_fullStr lptG contributes to changes in membrane permeability and the emergence of multidrug hypersusceptibility in a cystic fibrosis isolate of Pseudomonas aeruginosa
title_full_unstemmed lptG contributes to changes in membrane permeability and the emergence of multidrug hypersusceptibility in a cystic fibrosis isolate of Pseudomonas aeruginosa
title_short lptG contributes to changes in membrane permeability and the emergence of multidrug hypersusceptibility in a cystic fibrosis isolate of Pseudomonas aeruginosa
title_sort lptg contributes to changes in membrane permeability and the emergence of multidrug hypersusceptibility in a cystic fibrosis isolate of pseudomonas aeruginosa
topic carbapenem resistance
cystic fibrosis
hypersusceptibility
lipopolysaccharides
lptG
subinhibitory
url https://doi.org/10.1002/mbo3.844
work_keys_str_mv AT lucasbharrison lptgcontributestochangesinmembranepermeabilityandtheemergenceofmultidrughypersusceptibilityinacysticfibrosisisolateofpseudomonasaeruginosa
AT randalcfowler lptgcontributestochangesinmembranepermeabilityandtheemergenceofmultidrughypersusceptibilityinacysticfibrosisisolateofpseudomonasaeruginosa
AT bahaabdalhamid lptgcontributestochangesinmembranepermeabilityandtheemergenceofmultidrughypersusceptibilityinacysticfibrosisisolateofpseudomonasaeruginosa
AT annaselmecki lptgcontributestochangesinmembranepermeabilityandtheemergenceofmultidrughypersusceptibilityinacysticfibrosisisolateofpseudomonasaeruginosa
AT nancydhanson lptgcontributestochangesinmembranepermeabilityandtheemergenceofmultidrughypersusceptibilityinacysticfibrosisisolateofpseudomonasaeruginosa